Postoprative analgesia effect by different doses of oxycodone hydrochlorid in Gastroscopy therapy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16010124

Enrollment

Unknown

Registered

2016-12-10

Start date

2016-12-12

Completion date

Unknown

Last updated

2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General surgery

Interventions

A:Small dose

B:Moderate dose

C:Commonly used dose

D:High dose

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ASA status I-II; aged 18-65 years old male and femal; BMI1825kg/m2; esophagealvarices grade G3.

Exclusion criteria

Exclusion criteria: Opioid drug allergy, use of monoamine oxidase inhibitor for a long time, severe hepatic and kidney disease, coagulopathy, bronchial asthma, chronic obstructive pulmonary diseases, pulmonary heart disease, intracranial hypertension, and inability to comprehend study-related procedures.

Design outcomes

Primary

Measure	Time frame
Respiratory depression;	—

Secondary

Measure	Time frame
Limb movements;Hypotension;	—

Contacts

Public ContactZhe-feng Quan

Beijing YouAn Hospital, Capital Medial University

15811190059@126.com+86 15811190059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026